content top

Valsava Retinopathy: Etiology, Treatment and Results

J. Castro-Navarro, C. González-Castaño, M. García-Fernández, A. García-Alonso, M. Fonollá-Gil (Oviedo, Spain) Purpose: To report the etiology, treatment and results of six patients with Valsalva retinopathy. Methods: Six patients with sudden visual acuity loss owing to Valsalva retinopathy, treated in our hospital in the last three years, were selected for this study. Two patients underwent 20-G vitrectomy, three patients were treated...

Read More

Series of Three Ranibizumab Injections for the Treatment of Retrofoveolar Neovascular Age-Related Macular Degeneration, Two and a Half-Year Follow-Up

http://www.evrs.eu/medias/2010/congress/Age-Related-Macular-Degeneration.flv Corinne Gonzalez (Toulouse, France) Advantages: Effective, efficient – Good functional results with same or less injections than protocol studies – secure but less restrictive follow-up – less recurrences, – more retinal protective, – lastly cheaper. Methods: 92 eyes of 81 patients, 25 men, 56 women, with retrofoveolar...

Read More

Series of 3 Ranibizumab Injections, for the Treatment of Macular Retinal Telangiectasia Type 1 after One-Year Follow

http://www.evrs.eu/medias/2010/congress/Vascular-Pathologies-in-Young-Patients.flv Corinne Gonzalez (Toulouse, France) Advantages: Effective, efficiency – Good functional results, better than usual treatments – more retinal protective, no grid laser scars – less recurrences. Methods: 12 eyes of 12 patients, 10 men, 2 women, with Type 1 idiopathic macular telangiectasia. Patients received intravitreal Ranibizumab, 3 times,...

Read More
content top